FAR Issue Vol. 51/No. 168 Section I  
Issue Date: August 28, 2025
 
Total number of notices in Section I:    6

Notice /
Adopted
Section Description ID Publish
Date
View Text Development
2-40.008
The proposed rule development is intended to reschedule Xylazine, a drug product approved by the U.S. Food and Drug Administration (FDA) as an Animal Drug Product, from a Schedule I to a Schedule I with exception for Veterinary .... 29929464 8/28/2025
Vol. 51/168
View Text Development
61B-19.004
The proposed new rule establishes the education and training requirements for directors of homeowners’ associations in accordance with section 720.3033, F.S. [per HB 1203 (ch. 2024-221)]. It applies to elected or appointed .... 29930919 8/28/2025
Vol. 51/168
View Text Development
64B8-51.004
The Board proposes the rule and incorporated form are amended to reduce from three years to two years, the required length of time applicants must have practiced the profession over the preceding four year period as amended .... 29926263 8/28/2025
Vol. 51/168
View Text Development
64B8-55.002
The Board proposes the rule amendment to add an additional citation for a violation of license law as created by SB 1808 and set forth in Chapter 2025-48, Laws of Florida, relating to refunding overpayments to patients. .... 29926166 8/28/2025
Vol. 51/168
View Text Development
64B8-55.001
The Board proposes the rule amendment to add an additional violation of license law as created by SB 1808 and set forth in Chapter 2025-48, Laws of Florida, relating to refunding overpayments to patients. You will need to .... 29926069 8/28/2025
Vol. 51/168
View Text Development
65E-5.170
......
The amendments will revise Baker Act treatment (voluntary and involuntary) forms and regulations to comply with updated statutory requirements. 29927621 8/28/2025
Vol. 51/168